Total Payments
$2,288
2023 Payments
$1,212
Companies
21
Transactions
68
Medicare Patients
2,645
Medicare Billing
$308,866
Payment Breakdown by Category
Travel$1,154 (50.5%)
Food & Beverage$1,086 (47.5%)
Gifts$36.36 (1.6%)
Consulting$10.99 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,154 | 3 | 50.5% |
| Food and Beverage | $1,086 | 61 | 47.5% |
| Gift | $36.36 | 3 | 1.6% |
| Consulting Fee | $10.99 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,330 | 7 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $300.58 | 16 | $0 (2021) |
| AbbVie Inc. | $201.97 | 14 | $0 (2021) |
| Gilead Sciences, Inc. | $45.15 | 3 | $0 (2021) |
| Nestle HealthCare Nutrition Inc. | $43.93 | 2 | $0 (2021) |
| Braintree Laboratories, Inc. | $36.36 | 3 | $0 (2021) |
| Allergan, Inc. | $35.68 | 3 | $0 (2020) |
| IRONWOOD PHARMACEUTICALS, INC | $33.48 | 2 | $0 (2020) |
| QOL Medical, LLC | $32.73 | 2 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $31.57 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,212 | 6 | Boston Scientific Corporation ($1,212) |
| 2021 | $294.52 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($118.11) |
| 2020 | $220.61 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($54.46) |
| 2019 | $261.70 | 11 | Boston Scientific Corporation ($117.97) |
| 2018 | $230.19 | 14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($65.08) |
| 2017 | $69.49 | 5 | AbbVie, Inc. ($26.78) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/12/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Travel and Lodging | Cash or cash equivalent | $370.13 | General |
| Category: EXALT Model D_ENDO | ||||||
| 05/12/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Travel and Lodging | Cash or cash equivalent | $80.15 | General |
| Category: EXALT Model D_ENDO | ||||||
| 05/12/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | Cash or cash equivalent | $41.52 | General |
| Category: EXALT Model D_ENDO | ||||||
| 03/03/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: EXALT Model D_ENDO | ||||||
| 03/02/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Travel and Lodging | In-kind items and services | $704.20 | General |
| Category: EXALT Model D_ENDO | ||||||
| 03/01/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: EXALT Model D_ENDO | ||||||
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Gastroenterology | ||||||
| 09/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Gastroenterology | ||||||
| 09/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Gastroenterology | ||||||
| 08/16/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Gastroenterology | ||||||
| 07/21/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: IMMUNOLOGY | ||||||
| 07/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Gastroenterology | ||||||
| 06/11/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $11.92 | General |
| Category: GI COLON PREP | ||||||
| 05/17/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/20/2021 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Opioid Antagonist | ||||||
| 04/12/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.67 | General |
| 04/02/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/22/2021 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | Cash or cash equivalent | $12.22 | General |
| Category: GI COLON PREP | ||||||
| 03/22/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $12.22 | General |
| Category: GI COLON PREP | ||||||
| 02/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Gastroenterology | ||||||
| 02/01/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/16/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2020 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Opioid Antagonist | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 441 | 469 | $206,784 | $46,177 |
| 2022 | 12 | 557 | 617 | $196,019 | $55,600 |
| 2021 | 16 | 795 | 826 | $693,369 | $100,663 |
| 2020 | 15 | 852 | 907 | $751,797 | $106,426 |
Total Patients
2,645
Total Services
2,819
Medicare Billing
$308,866
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 92 | $34,316 | $12,140 | 35.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 91 | $44,863 | $6,567 | 14.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 84 | $11,352 | $5,084 | 44.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 47 | $10,013 | $4,332 | 43.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 30 | 31 | $19,251 | $3,967 | 20.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 16 | 17 | $25,160 | $3,936 | 15.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 24 | $19,536 | $3,575 | 18.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 27 | $11,286 | $2,372 | 21.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,318 | $1,711 | 39.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $9,698 | $1,406 | 14.5% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 13 | 13 | $16,029 | $588.91 | 3.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $962.00 | $498.94 | 51.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 94 | $35,062 | $14,130 | 40.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 92 | 93 | $23,622 | $9,435 | 39.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 152 | $20,368 | $8,284 | 40.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 83 | $41,300 | $7,219 | 17.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 52 | $10,036 | $4,018 | 40.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $15,525 | $3,329 | 21.4% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 11 | 11 | $16,280 | $2,331 | 14.3% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $12,210 | $2,213 | 18.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 25 | $10,450 | $2,023 | 19.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 43 | $3,182 | $1,261 | 39.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $2,418 | $997.10 | 41.2% |
| 43236 | Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $5,566 | $358.55 | 6.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 96 | 98 | $145,646 | $19,011 | 13.1% |
About Dr. Marc New, MD
Dr. Marc New, MD is a Gastroenterology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831170612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc New, MD has received a total of $2,288 in payments from pharmaceutical and medical device companies, with $1,212 received in 2023. These payments were reported across 68 transactions from 21 companies. The most common payment nature is "Travel and Lodging" ($1,154).
As a Medicare-enrolled provider, New has provided services to 2,645 Medicare beneficiaries, totaling 2,819 services with total Medicare billing of $308,866. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Oklahoma City, OK
- Active Since 11/09/2005
- Last Updated 01/27/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831170612
Products in Payments
- EXALT Model D (Device) $1,212
- XIFAXAN (Drug) $174.32
- ORISE (Device) $117.97
- HUMIRA (Biological) $63.39
- Humira (Biological) $60.27
- ZENPEP (Drug) $43.93
- LINZESS (Drug) $40.72
- TRULANCE (Drug) $40.68
- Trulance (Drug) $31.57
- Movantik (Drug) $29.80
- GATTEX (Drug) $24.36
- SUTAB (Drug) $24.14
- UCERIS (Drug) $23.65
- OCALIVA (Drug) $23.40
- Creon (Drug) $22.60
- UCERIS TABLETS (Drug) $21.79
- SUCRAID (Drug) $20.64
- PLENVU (Drug) $20.50
- XIFIXAN (Drug) $19.64
- XIFAXANIBSD (Drug) $19.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oklahoma City
George Salem, Md, MD
Gastroenterology — Payments: $872,730
Gastroenterology $872,730
Tauseef Ali, M.d, M.D
Gastroenterology — Payments: $616,367
Gastroenterology $616,367
Pooja Singhal
Gastroenterology — Payments: $178,683
Gastroenterology $178,683
Matthew Mcbride, Md, MD
Gastroenterology — Payments: $83,407
Gastroenterology $83,407
Dr. Trushar Patel, M.d, M.D
Gastroenterology — Payments: $81,054
Gastroenterology $81,054
Dr. David Stokesberry, M.d, M.D
Gastroenterology — Payments: $41,079
Gastroenterology $41,079